INCY

NASDAQ · Biotechnology

Incyte Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$90.62

+0.17 (+0.19%)

As of Mar 24, 9:39 PM ET ·

Analyst Consensus

Hold

Analysts

Very High

Coverage

Buy 17 52%

Hold 15 45%

Sell 1 3%

Price Target

Analyst Price Target +128.2% upside

Low Target $125.25

Average Target $206.81

High Target $260.19

Current Price $90.62

Current
$90.62

Target
$206.81

$125.25 $206.81 avg $260.19

Scenario Analysis

Bear Case

$125.25

38.2%

Low target

Base Case

$206.81

+128.2%

Avg target

Bull Case

$260.19

+187.1%

High target

Risk/Reward

4.9x

Highly favorable

Price in Context

52-Week High

$112.29

-19.3% from high

52-Week Low

$53.56

+69.2% from low

50-Day SMA

$101.74

-10.9% vs SMA

200-Day SMA

$86.15

+5.2% vs SMA

RSI (14)

51.1

Neutral

Target vs 52W High

$206.81

+84.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+25.5%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.2%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-66.8%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	+3.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-26.5%